Evidence map›Paper›PMID 38534101›Full record

ArticleAntimicrobial agents and chemotherapy2024

Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin.

Praharshinie Rupasinghe, Azka Ashraf, Nadia Barreda, Shafiqua Parveen, Muhammad Zubair, Roger Calderon, Sunil Asif, Nilma Hirani, Layila Chingisova, Atang Bulane and 9 more

Abstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Heteroresistance inFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Praharshinie RupasingheUnit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-9858-8935
Azka AshrafThe Indus Hospital laboratory, Karachi, Pakistan.
Nadia BarredaSocios en Salud, Lima, Peru.
Shafiqua ParveenThe Indus Hospital laboratory, Karachi, Pakistan.
Muhammad ZubairThe Indus Hospital laboratory, Karachi, Pakistan.
Roger CalderonSocios en Salud, Lima, Peru.ORCID 0000-0001-8932-0489
Sunil AsifThe Indus Hospital laboratory, Karachi, Pakistan.
Nilma HiraniDepartment of Microbiology, Sir JJ Hospital, Mumbai, India.
Layila ChingisovaNational Tuberculosis Reference Lab, Almaty, Kazakhstan.
Atang BulaneCenter for Tuberculosis, National Institute of Communicable Diseases, Mohakhali, South Africa.
Pham Thu HangRegional Tuberculosis Reference Lab, Ho Chi Minh, Vietnam.
Doan Thu HaNational Tuberculosis Reference Lab, Hanoi, Vietnam.
Elisa ArdizzoniUnit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-3562-9194
Nazia KursheedThe Indus Hospital laboratory, Karachi, Pakistan.
Willem Bram De RijkUnit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.
Leen RigoutsUnit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-3301-9480
Lorenzo GuglielmettiMedical Department, MSF, Paris, France.
Carol MitnickBrigham and Women's Hospital, Boston, Massachusetts, USA.
Bouke C de JongUnit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium.

Funding

Médecins Sans Frontières (MSF) endTB,endTB Q
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Microbial Sensitivity TestsMycobacterium tuberculosisRifampinAntitubercular AgentsHumansAntitubercular AgentsRifampinborderline rpoB mutationsMycobacterium tuberculosisrifampicin

Identifiers

PMID38534101
PMCPMC11064607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.